Cargando…

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom

PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has...

Descripción completa

Detalles Bibliográficos
Autores principales: Arana, Alejandro, Margulis, Andrea V, Varas‐Lorenzo, Cristina, Bui, Christine L, Gilsenan, Alicia, McQuay, Lisa J, Reynolds, Maria, Rebordosa, Cristina, Franks, Billy, de Vogel, Stefan, Appenteng, Kwame, Perez‐Gutthann, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821285/
https://www.ncbi.nlm.nih.gov/pubmed/33091194
http://dx.doi.org/10.1002/pds.5150
_version_ 1783639389268606976
author Arana, Alejandro
Margulis, Andrea V
Varas‐Lorenzo, Cristina
Bui, Christine L
Gilsenan, Alicia
McQuay, Lisa J
Reynolds, Maria
Rebordosa, Cristina
Franks, Billy
de Vogel, Stefan
Appenteng, Kwame
Perez‐Gutthann, Susana
author_facet Arana, Alejandro
Margulis, Andrea V
Varas‐Lorenzo, Cristina
Bui, Christine L
Gilsenan, Alicia
McQuay, Lisa J
Reynolds, Maria
Rebordosa, Cristina
Franks, Billy
de Vogel, Stefan
Appenteng, Kwame
Perez‐Gutthann, Susana
author_sort Arana, Alejandro
collection PubMed
description PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has not been thoroughly assessed in the United Kingdom Clinical Practice Research Datalink's (CPRD's) GOLD database. We explored the validity of algorithms to identify cardiovascular outcomes and risk factors and evaluated different outcome‐identification strategies using these algorithms for estimation of adjusted incidence rate ratios (IRRs). METHODS: First, we identified AMI, stroke, smoking, obesity, and menopausal status in a cohort treated for overactive bladder by applying computerized algorithms to primary care medical records (2004–2012). We validated these cardiovascular outcomes and risk factors with physician questionnaires (gold standard for this analysis). Second, we estimated IRRs for AMI and stroke using algorithm–identified and questionnaire–confirmed cases, comparing these with IRRs from cases identified through linkage with hospitalization/mortality data (best estimate). RESULTS: For AMI, the algorithm's positive predictive value (PPV) was >90%. Initial algorithms for stroke performed less well because of inclusion of codes for prevalent stroke; algorithm refinement increased PPV to 80% but decreased sensitivity by 20%. Algorithms for smoking and obesity were considered valid. IRRs based on questionnaire‐confirmed cases only were closer to IRRs estimated from hospitalization/mortality data than IRRs from algorithm‐identified cases. CONCLUSIONS: AMI, stroke, smoking, obesity, and postmenopausal status can be accurately identified in CPRD. Physician questionnaire–validated AMI and stroke cases yield IRRs closest to the best estimate.
format Online
Article
Text
id pubmed-7821285
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78212852021-01-29 Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom Arana, Alejandro Margulis, Andrea V Varas‐Lorenzo, Cristina Bui, Christine L Gilsenan, Alicia McQuay, Lisa J Reynolds, Maria Rebordosa, Cristina Franks, Billy de Vogel, Stefan Appenteng, Kwame Perez‐Gutthann, Susana Pharmacoepidemiol Drug Saf Original Reports PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has not been thoroughly assessed in the United Kingdom Clinical Practice Research Datalink's (CPRD's) GOLD database. We explored the validity of algorithms to identify cardiovascular outcomes and risk factors and evaluated different outcome‐identification strategies using these algorithms for estimation of adjusted incidence rate ratios (IRRs). METHODS: First, we identified AMI, stroke, smoking, obesity, and menopausal status in a cohort treated for overactive bladder by applying computerized algorithms to primary care medical records (2004–2012). We validated these cardiovascular outcomes and risk factors with physician questionnaires (gold standard for this analysis). Second, we estimated IRRs for AMI and stroke using algorithm–identified and questionnaire–confirmed cases, comparing these with IRRs from cases identified through linkage with hospitalization/mortality data (best estimate). RESULTS: For AMI, the algorithm's positive predictive value (PPV) was >90%. Initial algorithms for stroke performed less well because of inclusion of codes for prevalent stroke; algorithm refinement increased PPV to 80% but decreased sensitivity by 20%. Algorithms for smoking and obesity were considered valid. IRRs based on questionnaire‐confirmed cases only were closer to IRRs estimated from hospitalization/mortality data than IRRs from algorithm‐identified cases. CONCLUSIONS: AMI, stroke, smoking, obesity, and postmenopausal status can be accurately identified in CPRD. Physician questionnaire–validated AMI and stroke cases yield IRRs closest to the best estimate. John Wiley & Sons, Inc. 2020-10-28 2021-02 /pmc/articles/PMC7821285/ /pubmed/33091194 http://dx.doi.org/10.1002/pds.5150 Text en © 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Reports
Arana, Alejandro
Margulis, Andrea V
Varas‐Lorenzo, Cristina
Bui, Christine L
Gilsenan, Alicia
McQuay, Lisa J
Reynolds, Maria
Rebordosa, Cristina
Franks, Billy
de Vogel, Stefan
Appenteng, Kwame
Perez‐Gutthann, Susana
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title_full Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title_fullStr Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title_full_unstemmed Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title_short Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
title_sort validation of cardiovascular outcomes and risk factors in the clinical practice research datalink in the united kingdom
topic Original Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821285/
https://www.ncbi.nlm.nih.gov/pubmed/33091194
http://dx.doi.org/10.1002/pds.5150
work_keys_str_mv AT aranaalejandro validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT margulisandreav validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT varaslorenzocristina validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT buichristinel validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT gilsenanalicia validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT mcquaylisaj validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT reynoldsmaria validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT rebordosacristina validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT franksbilly validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT devogelstefan validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT appentengkwame validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom
AT perezgutthannsusana validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom